Expo-Net Danmark A/S v Buono-Net Australia Pty Ltd (No 2)

Link copied
Case Copied 27 min read

FEDERAL COURT OF AUSTRALIA

Expo-Net Danmark A/S v Buono-Net Australia Pty Ltd (No 2) [2011] FCA 710

Citation: Expo-Net Danmark A/S v Buono-Net Australia Pty Ltd (No 2) [2011] FCA 710
Parties: EXPO-NET DANMARK A/S v BUONO-NET AUSTRALIA PTY LTD, RAFFAELE BUONO and CLELIA BUONO
File number: NSD 428 of 2009
Judge: BENNETT J
Date of judgment: 23 June 2011
Catchwords:

PATENTS – whether failure to describe best method known to applicant of performing invention pursuant to
s 40(2)(a) of Patents Act 1990 (Cth) – criteria by which to establish failure to describe best method – whether this ground of invalidity should be considered in isolation from other asserted grounds of invalidity in a summary dismissal application – relevance of disclosure to the skilled reader – conflicting evidence – evidence that choice was routine

PRACTICE AND PROCEDURE – summary dismissal application pursuant to s 31A of Federal Court of Australia Act 1976 (Cth)

Legislation: Federal Court of Australia Act 1976 (Cth) s 31A
Patents Act 1990 (Cth) s 40(2)(a)
Cases cited: Apotex Pty Ltd v Les Laboratoires Servier (No 4) (2010) 89 IPR 274 cited
Colgate Palmolive Co v Cussons Pty Ltd & Anor (1993) 26 IPR 311 discussed
Dey v Victorian Railways Commissioners (1949) 78 CLR 62 cited
Enka BV v E I Dupont De Nemours & Co (1987) BP 13 (TPD) discussed
Firebelt Pty Ltd v Brambles Australia Ltd (2000) 51 IPR 531 discussed
General Steel Industries Inc v Commissioner for Railways (NSW) (1964) 112 CLR 125 cited
Kowalski v MMAL Staff Superannuation Fund Pty Ltd (2009) 178 FCR 401 cited
Pfizer Overseas Pharmaceuticals & Ors v Eli Lilly & Co (2005) 225 ALR 416 cited
Spencer v Commonwealth of Australia (2010) 241 CLR 118 applied
Theseus Exploration NL v Foyster (1972) 126 CLR 507 cited
Three Rivers District Council v Bank of England (No 3) [2003] 2 AC 1 cited
Date of hearing: 6 June 2011
Place: Sydney
Division: GENERAL DIVISION
Category: Catchwords
Number of paragraphs: 58
Counsel for the Applicant: Mr S Burley SC with Mr A Fox
Solicitor for the Applicant: Watermark Intellectual Property Lawyers
Counsel for the Respondents: Mr A Franklin SC
Solicitor for the Respondents: Maxwell IP

IN THE FEDERAL COURT OF AUSTRALIA

NEW SOUTH WALES DISTRICT REGISTRY

GENERAL DIVISION

NSD 428 of 2009

BETWEEN:

EXPO-NET DANMARK A/S
Applicant

AND:

BUONO-NET AUSTRALIA PTY LTD
First Respondent

RAFFAELE BUONO
Second Respondent

CLELIA BUONO
Third Respondent

JUDGE:

BENNETT J

DATE OF ORDER:

23 JUNE 2011

WHERE MADE:

PERTH (BY VIDEO LINK TO SYDNEY)

THE COURT ORDERS THAT:

1.The application by the respondent pursuant to s 31A of the Federal Court of Australia Act 1976 (Cth) be dismissed.

2.The applicant file and serve submissions as to costs by 30 June 2011.

3.The respondent file and serve submissions as to costs by 7 July 2011.

Note:Settlement and entry of orders is dealt with in Order 36 of the Federal Court Rules.
The text of entered orders can be located using Federal Law Search on the Court’s website.

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Expo-Net Danmark A/S v Buono-Net Australia Pty Ltd (No 2) and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2011] FCA 710
Decision Date

CaseChat Overview and Summary

The case of Expo-Net Danmark A/S v Buono-Net Australia Pty Ltd (No 2) involved a dispute over the validity of a patent under the Patents Act 1990 (Cth). The primary legal issue before the court was whether the patent was invalid due to a failure to describe the best method known to the applicant of performing the invention, as required by section 40(2)(a) of the Patents Act. Specifically, the court had to determine the criteria for establishing such failure and whether this ground of invalidity should be considered in isolation from other asserted grounds of invalidity in a summary dismissal application. The court also had to assess the relevance of the disclosure to the skilled reader, especially in light of conflicting evidence and the evidence that the choice of foaming agent was a matter of routine experimentation.

The court examined the evidence provided by both parties and concluded that the patent in question was a process that involved several parameters, including ingredients and machinery, to achieve a desired result. The patent did not specify any particular foaming agent, which was an essential element of the invention. The court noted that while the evidence suggested that the skilled reader found the invention obvious and that achieving the claimed result was a matter of routine experimentation, there was conflicting evidence about the necessity of disclosing the choice of foaming agent. The court held that the determination of whether a specific foaming agent needed to be disclosed was a complex issue that was not suitable for summary dismissal and required a more detailed examination. The court also considered that the evidence provided by Expo-Net showed that their position was at least reasonably arguable.

In light of the above, the court dismissed the application by Buono-Net for summary dismissal under section 31A of the Federal Court of Australia Act 1976 (Cth). The court ordered that both parties file and serve their submissions on costs by specified dates. This decision highlights the importance of carefully considering the complexities of patent validity issues, particularly in cases involving routine experimentation and conflicting evidence.

Orders

Orders of the court

1. The application by the respondent pursuant to s 31A of the Federal Court of Australia Act 1976 (Cth) be dismissed.

2. The applicant file and serve submissions as to costs by 30 June 2011.

3. The respondent file and serve submissions as to costs by 7 July 2011.

Note:

Background

Background to the litigation

The case involves a dispute over the validity of a patent held by Expo-Net Danmark A/S, with a cross-claim for revocation by Buono-Net Australia Pty Ltd. The patent in question relates to a method of producing a contact filter block using a foaming additive within the process. The foaming additive is an essential component of the claims, although the specific type of foaming additive is not detailed in the claims. The process involves using a foaming agent to create a fluffier product with improved insulating properties and cost efficiency. The inventor, Mr Klinkby, conducted extensive experiments with various foaming agents between 2000 and 2001 to determine the most effective foaming agent for the process. Through these experiments, he identified a foaming agent that provided the best result without causing the product to foam excessively. However, there is no evidence that this foaming agent was the best method known to Mr Klinkby at the priority date of the patent application.

This case involves a summary dismissal application under section 31A of the Federal Court of Australia Act 1976 (Cth). Buono-Net Australia Pty Ltd filed a cross-claim for revocation of Expo-Net Danmark A/S's patent, asserting that the patent fails to comply with section 40(2)(a) of the Patents Act 1990 (Cth) due to insufficient disclosure of the best method known to the applicant of performing the invention. The application for summary dismissal was brought before the court, which considered whether there were grounds to dismiss the cross-claim without a full hearing. The court reviewed the evidence and submissions to determine if Expo-Net had a reasonable prospect of defending the cross-claim.

Evidence

Evidence Before The Court

There is no dispute that the foaming additive is an essential integer of the claims. The claims do not specify any particular foaming additive. The only further claimed characterisations within the claimed method are in claim 2 of the Patents, that the weight of the foaming additive constitutes 3 to 10 per cent of the weight of granulate material, and in claim 5 of the Patents (the apparatus claim), in which the foaming additive has a melting point apparently different to that of the granulate material.THE EVIDENCE AND THE SUBMISSIONSBuono-Net Buono-Net relies on evidence filed by Expo-Net in an affidavit of the inventor, Mr Klinkby. Mr Klinkby describes the steps taken in the development of the “BIO-BLOK”, apparently the contact filter block of the invention, produced by the claimed method. The first date of filing of the Patents was 23 March 2006. Mr Klinkby’s affidavit describes a period, relevantly, from 2000 to 2001. Mr Klinkby states that when experimenting with a particular granulate of material he incorporated:…some foaming agent into the formulation to foam the product creating a fluffier product with ‘give’ so it would absorb some force. At that time I was aware that foaming agent could be used to make a product fluffier and bigger, giving it better insulating properties and reducing the amount of raw material needed to manufacture the product (thus also making it cheaper to manufacture). Mr Klinkby says that he thought that he might be able to incorporate foaming agent into the BIO-BLOK in order to roughen the surface. This was in the context of looking for a cheaper product. He explains that he was not sure if that foaming agent would work and that he had certain concerns about it but thought that it might be possible to use foaming agent to achieve the roughness and reduction in the raw materials he needed. Mr Klinkby then decided to test whether he could use foaming agent and still achieve a viable product, by testing a number of different foaming agents using a specific granulate of material, “virgin HDPE”. This was in order to remove variables introduced into the extrusion process. He obtained a number of foaming agents that were compatible with HDPE – approximately six over a period of six months. He tested each foaming agent in increasing percentages, keeping all other parameters the same. By the end of the tests (in about 2001) he found, as stated in his affidavit, that:a.One or two of the foaming agents I tried did not create a rough surface at all.b.One or two of the foaming agents did produce a somewhat rough surface.c.At least two of the foaming agents caused the products to foam too much which made the extrusion impossible to control, and no useable product resulted. Mr Klinkby says that at the end of the series of experiments, he discounted the foaming agents that did not work and picked the one foaming agent that provided the best result. He says:I was very surprised by the amount of roughness I could achieve with this foaming agent, without the foaming becoming uncontrollable and thus the product unuseable. However I was still concerned that even with this foaming agent the resulting product would not be viable.

Decision

Reasons for decision

Issues
1. Whether the failure to describe the best method known to the applicant of performing the invention pursuant to section 40(2)(a) of the Patents Act 1990 (Cth) has been established.
2. What criteria should be applied to establish a failure to describe the best method in the context of this case.
3. Whether the ground of invalidity should be considered in isolation from other asserted grounds of invalidity in a summary dismissal application.
4. What is the relevance of the disclosure to the skilled reader in the context of conflicting evidence and routine experimentation.
5. Whether the choice of foaming agent was a matter of routine and common general knowledge for the skilled reader.

Held
1. The court concluded that there was a reasonable prospect that the respondent could successfully defend the cross claim for revocation based on the failure to describe the best method known to the applicant pursuant to section 40(2)(a) of the Patents Act 1990 (Cth).
2. The court determined that the criteria for establishing a failure to describe the best method in the context of this case include the need for sufficient instruction to enable the person of ordinary skill to work the invention without undue experimentation and the relevance of the experimental results to the claimed process.
3. The court held that the ground of invalidity should not be considered in isolation from other asserted grounds of invalidity in a summary dismissal application.
4. The court found that the relevance of the disclosure to the skilled reader in the context of conflicting evidence and routine experimentation was a complex question that was not suited to summary dismissal.
5. The court concluded that the choice of foaming agent was a matter that could be part of the common general knowledge of the person of ordinary skill in the art and was a matter of routine experimentation.

Ratio Decidendi

Legal Principle Established

Further, Expo-Net submits, Buono-Net has not established that the confined and restricted processes the subject of those experimental results were the best method known to Mr Klinkby as at the priority date.CONSIDERATION The claimed invention is to a process utilising a number of parameters, being ingredients and machinery, to achieve a desired result. While some of the dependent claims give more specificity, generally speaking there is no claimed limitation on the different integers of the combination. That includes the foaming agent. There is evidence that the foaming agent is susceptible to temperature and that different foaming agents will melt, which they must do for the process, at different temperatures. This may depend in turn on the other integers of the combination. The Patents define foaming agent by reference to the desired result to be achieved. Where a claimed invention is described without limitation or further specificity with regard to the individual integers, an argument that the description in the specification is insufficient may be available. However, this would normally be within what has been described as the first limb of s 40(2)(a), that is that there is insufficient instruction to enable the person of ordinary skill to work the invention without inventive step or undue experimentation. However, that is not the basis for this application. Buono-Net says that there was a best method of performing the invention known to the inventor and not disclosed. In my view, Expo-Net has a reasonable prospect of defending Buono-Net’s cross claim for revocation for failure to comply with s 40(2)(a) of the Act on two bases:·There is evidence in the proceedings that the skilled reader of the specification, whose common general knowledge is relevant in an assessment of necessary disclosure of the method of performing the invention, finds the invention obvious and says that it is a matter of routine to achieve the result claimed.·Mr Klinkby’s evidence relates to an early period in the experimentation leading to the invention. Importantly, the claimed invention involves an interaction of integers and routine adjustment of variables to obtain a workable result from the use of foaming agent. Mr Klinkby’s evidence was of experiments in which all of those variables, other than the use of foaming agent, were fixed. This may or may not affect the working of the foaming agent in a practical performance of the invention. The High Court pointed out in Spencer that care must be taken in making an order under s 31A of the FC Act, in particular in cases involving complex facts. It is a complex question to determine the need for a description or disclosure of details of the choice of foaming agent to the skilled reader where there is expert evidence that such matters were part of the common general knowledge of the person of ordinary skill in the art and were matters of routine experimentation. The determination of the need for the description of particular foaming agents, or the consequences of the fact that some foaming agents did not work in the experimental process, is not one that lends itself to this application. Not only is there conflicting evidence on the subject, there is also the question of the relevance of those experimental results. For example and by analogy, evidence would need to be led to establish whether there was a requirement to disclose a failed in vitro test of a compound in artificial conditions when the claimed use of the compound was in vivo under different conditions. It may be that there is such an obligation and that the early experimental results are relevant to the later developed claimed process, but that is not established on the evidence presently relied on. It is not accepted by Expo-Net and Expo-Net’s position is, at least, reasonably arguable.